chrisvoncsefalvay/vaers-outcomes huggingface dataset:
extrapyramidal symptoms; body started jerking; couldn't walk; legs buckled; sick for two days from the second vaccination/woke up and felt so ill; slept the whole day; bad reactions/scary reactions; vomited like mad; This spontaneous case was reported by a consumer and describes the occurrence of EXTRAPYRAMIDAL DISORDER (extrapyramidal symptoms), DYSKINESIA (body started jerking), GAIT INABILITY (couldn't walk), LIMB DISCOMFORT (legs buckled) and ILLNESS (sick for two days from the second vaccination/woke up and felt so ill) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (The patient put off having the vaccination because they felt they had antibodies.) in January 2021 and Hip surgery (bad back). Concomitant products included PARACETAMOL (TYLENOL), GABAPENTIN, TRAMADOL, IRON, OLMESARTAN, ATORVASTATIN, LORATADINE and MONTELUKAST for an unknown indication.    On 09-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXTRAPYRAMIDAL DISORDER (extrapyramidal symptoms), DYSKINESIA (body started jerking), GAIT INABILITY (couldn't walk), LIMB DISCOMFORT (legs buckled), ILLNESS (sick for two days from the second vaccination/woke up and felt so ill), HYPERSOMNIA (slept the whole day), VACCINATION COMPLICATION (bad reactions/scary reactions) and VOMITING (vomited like mad). The patient was treated with ONDANSETRON for Vomiting, at a dose of 1 dosage form. On 09-Sep-2021, VOMITING (vomited like mad) had resolved. At the time of the report, EXTRAPYRAMIDAL DISORDER (extrapyramidal symptoms), DYSKINESIA (body started jerking), GAIT INABILITY (couldn't walk), LIMB DISCOMFORT (legs buckled), ILLNESS (sick for two days from the second vaccination/woke up and felt so ill), HYPERSOMNIA (slept the whole day) and VACCINATION COMPLICATION (bad reactions/scary reactions) outcome was unknown.            The patient was visiting her children at the moment and expresses her concerns about future travel requiring the booster dose. She wanted to know what to do if she wanted to travel but doesn't want to take the third booster dose. She said they wont let her travel without taking it. She asked if she should take the third booster dose.   This case was linked to MOD-2021-344049 (Patient Link).; Sender's Comments: This case concerns a 71-year-old female patient with no relevant medical history, who experienced the unexpected event of hypersomnia. The event occurred on the same day after the second dose of mRNA-1273 (Moderna COVID-19 Vaccine). The benefit-risk relationship of mRNA-1273 (Moderna COVID-19 Vaccine) is not affected by this report.
Patient was held by mom sprayed on Gebauer's topical anesthetic each thigh, 2 injections right leg, one left leg, had Tylenol at home, immediately after injection started crying, very pale, held mom until for 15 min., color improving, pulse ox 98% RA, heart rate: 110, 96.6F Temperature.
The report was first received from practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 12-JAN-2018, the patient was vaccinated with ROTATEQ (strength were unknown, lot# N003984 and expiration date 19-NOV-2018) 1 dose form orally for prophylaxis (product storage error). No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017 was 47 degree Celsius for max 15 hours. And on 07-DEC-2017 was 50 degree Celsius for max 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001958.
Congestion; Sore throat; Fatigue; Heat at the site of injection; Redness at the site of injection; swelling at the site of injection; Itchiness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Heat at the site of injection), NASAL CONGESTION (Congestion), OROPHARYNGEAL PAIN (Sore throat), VACCINATION SITE ERYTHEMA (Redness at the site of injection) and VACCINATION SITE SWELLING (swelling at the site of injection) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concomitant products included PROGESTERONE, TRAZODONE and AZELASTINE for an unknown indication.  On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Heat at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE SWELLING (swelling at the site of injection) and VACCINATION SITE PRURITUS (Itchiness at the site of injection). On 21-Feb-2021, the patient experienced FATIGUE (Fatigue). On 24-Feb-2021, the patient experienced NASAL CONGESTION (Congestion) and OROPHARYNGEAL PAIN (Sore throat). On 23-Feb-2021, FATIGUE (Fatigue) had resolved. At the time of the report, VACCINATION SITE WARMTH (Heat at the site of injection), VACCINATION SITE ERYTHEMA (Redness at the site of injection), VACCINATION SITE SWELLING (swelling at the site of injection) and VACCINATION SITE PRURITUS (Itchiness at the site of injection) had not resolved and NASAL CONGESTION (Congestion) and OROPHARYNGEAL PAIN (Sore throat) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Nyquil (doxylamin-PSE-DM-acetaminophen),  Daiquil (Acetaminophen, Dextromethorphan, and Pseudoephedrin), anti itch cream with lidocaine, moisturizer, aloe vera.
PATIEN STARTED TO EXPERIANCE A THROBBING HEADACHE APROXAMATELY AN HOUR AFTER THE VACCINE, PATIENT ALSO NOTED AN ELIVATED HEART RATE AND  DID ALSO SAY HE WAS HAVING TROUBLE CATCHING HIS BREATH, BUT SAID IT WAS PROBOBLY BECAUSE OF HIS MASK HE WAS WEARING., PATIENT WAS MAINLY CONCERNED ABOUT HEADACHE. PATIENT WAS WALKED IN BACK TO THE CLINICAL SERVICE ROOM NEXT TO PHARMACY SO HE COULD BE MONITORED SOME MORE , I ASKED IF WAS EXRIENCING  ANY MORE SYSPTOMS,NEGATIVE.  COUNSLED ON POST VACCINE ADVERSE EVENTS AND THAT HE COULD EXPERIANCE MORE SYMPTOMS LATER ON SUCH AS FEVER,CHILLS  AND WAS COUNSLED OTC SOLUTIONS TO TREAT. WAS OFFRED AND ACCEPTED OTC IBUPROFEN AND WATER. SINCE PATIENT WAS WORKING WHEN ADVERSE EVENT OCCURED , TALK TO STORE MANAGEMENT TO LET ASSOCIATE GO HOME SO THAT HE COULD REST. WAS SENT HOME TO REST.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history and concomitant therapies were not reported. Between 03-SEP-2017 and 11-SEP-2017, the patient was vaccinated with an improperly stored dose of PEDVAXHIB (lot # M003701, expiration date 01-NOV-2019 and lot # N003700, expiration date 01-NOV-2019) (dose and route were not reported) for prophylaxis. The vaccine was exposed to 8.5 Celsius degrees (°C) for 1 hour. There was no previous temperature excursion and also there was no "data logger". No adverse effects were reported. Lot number M003701 is an invalid lot number for haemophilus b conjugate vaccine (meningococcal protein conjugate). This is one of several reports from the same reporter. Sender's Comments: US-009507513-1709USA009437: US-009507513-1709USA009443: US-009507513-1709USA009439: US-009507513-1709USA009440: US-009507513-1709USA009441: US-009507513-1709USA009442: US-009507513-1709USA009436: US-009507513-1709USA009435: US-009507513-1709USA009438.
The parent signed him up for the Vaccine clinic thinking he would get Pfizer Covid vaccine.  The patient was 17 and 4 months.  The nurse stated he was getting Moderna, but the father did not hear this.  The father also received the Moderna EUA information for patient sheet.   The nurse did not see the age was under 18.   The patient is not having any untoward symptoms.   has no side effects . The patients doctor was consulted as was the CDC info line.  Patient was advised to obtain the second Moderna booster off label.
On 07/25/2022, after I ate lunch, I had a feeling of fullness in my stomach and felt bloated. That night, I ate a really small dinner because I was still feeling uncomfortable but not in pain. Later that evening, probably around 10 or 10:30 at night, I was having gastrointestinal type chest pain. It wasn't sharp pain, but it was hugely uncomfortable. I tried using a heating pad, but that didn't help and I started throwing up. I thought I might have a virus. It didn't go away, and it kept me up all night. Early in the next morning, I drove myself to the emergency room because I was concerned about a heart attack. They did an EKG and I believe they took some blood. The doctor informed me that I did the right thing by coming in because I had a heart enzyme (troponin) that was showing up as high which typically indicates a heart attack or heart blockage. They said that I had to be admitted at that time due to these high levels, but I was unable to be admitted until later that day and at a different location. I was there until that Friday evening. while there, they did a stress test and an angiogram. They discovered some inflammation in my heart, but they don't know what it was caused from. They prescribed a few medications that I have been taking ever since and I am still being monitored by doctors. I have seen a cardiologist since being discharged and the numbers have gone down. The cardiologist put me on a daily regimin of baby aspirin and atorvastatin. They also discovered a gallstone during an abdominal ultrasound but they do not feel that it would cause the issues with my heart.
About 1 hour after administration, patient was grocery shopping and felt like throat was closing and had a hard time breathing. She went to ER. No treatment at ER but sent RX for epi-pen and patient purchased benadryl OTC
Moderna booster 10/22/21 after J&J vaccine received 3/13/21 Morning of 10/26/21 woke with sore throat, white covering tonsils and throat.   Urgent care 11/14/21 diagnosis Thrush. Prescribed Nystatin oral suspension for 10 days.  Throat improved but did not clear completely and more noticeable on tongue. Telemedicine appointment 11/23/21 - prescribed Fluconazole 200 mg tablets - 1 taken 11/23, second taken 11/25.  Improvement but tongue still not cleared as of 12/2.  Telemedicine appointment set for 12/3 with Dr. (have never had Thrush previously)
But after my 3rd dose, I suffered a major flare; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Dec2021 as dose 3 (booster), single (Lot number: 33Q30BD) at the age of 39 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Obesity with no other pre-existing conditions" (unspecified if ongoing). Facility where the most recent COVID-19 vaccine was administered on Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has no known allergies. The patient did not have COVID prior to vaccination. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose Number: 1 , Batch/Lot No: EN6208 , Location of injection: Arm Right), administration date: 17Mar2021, when the patient was 38-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 2, Batch/Lot No: EW0150 , Location of injection: Arm Left), administration date: 07Apr2021, when the patient was 38-year-old, for COVID-19 immunization, reaction(s): "NSVT", "Tremors: The day after my 2nd, it started with a mild tremor in my hands", "Attacks of tachycardia", "Dysautonomia".  The following information was reported: CONDITION AGGRAVATED (hospitalization, disability), outcome "recovering", described as "But after my 3rd dose, I suffered a major flare". The patient was hospitalized for condition aggravated (hospitalization duration: 1 day(s)). The event "but after my 3rd dose, i suffered a major flare" required physician office visit and emergency room visit. Therapeutic measures were not taken as a result of condition aggravated. Clinical course: The day after patient's second, it started with a mild tremor in her hands. Over time symptoms progressed to attacks of tachycardia, NSVT, and tremors. She was as broadly diagnosed with Dysautonomia. At first, she didn't suspect vaccine and thought it was safe and effective. But after her third dose, she suffered a major flare and have improved since refraining from more boosters, though was still not recovered.
Looks like measles; Very very bad rash; Sore arm; A spontaneous report (United States) was received from a consumer concerning, a 59-year-old female patient, who received Moderna (mRNA-1273) vaccine and experienced a very severe rash on torso of body (rash) that looks like measles/rash (rash morbilliform) and sore arm (pain in extremity).  The patient's medical history was not provided. No Relevant concomitant medications were reported.  On 8 Mar 2021, prior to the onset of symptoms, the patient received their second of two planned doses of mRNA-1273 (Lot number: 013A21A) intramuscularly for prophylaxis of COVID-19 infection.   On 8 Mar 2021, the patient experienced soreness of arm.  On 10 Mar 2021, the patient had a very severe rash on torso of body. Rash has spread under their arms and coming down the arms and coming into patient's neck area. It was reported that the rashes on the patient's body looks like measles. The event, looks like Measles considered as Medically significant. Treatment information provided included Benadryl.  Action taken with mRNA-1273 in response to the event(s) was not applicable.  On an unknown date, the outcome of the event, sore arm was considered resolving.  On an unknown date, the outcome of the event, experienced a very severe rash on torso of body that looks like measles were considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Initial information received on 05-Dec-2018 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional. This case involves a 73 years old female patient who had intermittent redness and rash on her upper chest, tightness in her neck, generalized warm sensations, tachycardia, tremors, nerve pain, heat sensation in her right eye, electrical activity in her head and soreness at the injection site, lips are tingling and so are her legs while she received vaccine FLUZONE HIGH DOSE. The patient's past medical history included hypothyroid, hand tremors, nerve pain and heat sensation in her Right eye prior to the FLUZONE HD. Medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 29-Nov-2018, the patient received a 0.5 ml dose of suspect Influenza USP Trival A-B High Dose Subvirion Vaccine (lot number: LUI981AA and expiry date: 16-Mar-2019) (dose in series and site of administration was not reported) via intramuscular route. On an unknown date, following the vaccination the patient experienced soreness at the injection site, intermittent redness and rash on her upper chest. Patient had tachycardia on Monday night. Patient had gone to see her HCP x2 since the FLUZONE HD. On an unspecified date, patient had tightness in her neck, lips are tingling and so are her legs, electrical activity in her head and generalized warm  sensations. Patient was diagnosed with hand tremors prior to the FLUZONE HD and her hand tremors seem worse now. She has had nerve pain prior to the FLUZONE HD and now that seems worse, had a heat sensation in her Right eye prior to the FLUZONE HD and that may be a little more now. (Other relevant tests included no lab data.) Final diagnosis was rash, erythema, neck tightness, feeling of warmth, tachycardia, tremor, nerve pain, warmness in eyes, head banging and vaccination site pain hand tremors, lips are tingling and so are her legs and heat sensation in her Right eye. It was not reported if the patient received a corrective treatment. The outcome of the events was reported as unknown for all events. List of documents held by sender: none.
Patient had J/J vaccine on 3/14. Patient developed what appears to be a shingles rash on 3/18 or 3/19. She presented to the clinic for eval of rash on 3/20, which was dx as shingles rash. She was placed on valcyclovir 1000mg q 8 hours x 7 days and told to follow up with PCP on Monday AM.
A 76 y.o. male admitted to the hospital on 8/21/2022 for weakness after testing positive for COVID. History of anoxic brain injury from cardiac arrest in 1998 and limited mobility at home. D/C 8/25/2022. Discharge Diagnosis and Associated Hospital Course. Acute hypoxemic respiratory failure -Secondary to COVID. Some chronic lung changes on CT, history of pulmonary sarcoid years ago that has been stable. Also component of general debility and deconditioning.  -Initially hypoxic to 86-87% on RA, currently on 3L NC to maintain O2 sat > 90% but no increased work of breathing.  -Treatment of COVID as below. Incentive spirometer. Wean O2 for goal spO2 88-92%. COVID-19 infection- Presented with: cough, weakness, rhinorrhea- Symptom onset: 8/20- Positive COVID-19: 8/20 on home test and 8/21 - Vaccination status: Vaccinated with Pfizer and boosted x 2 with Pfizer. - CXR on admission showed possible edema and/or bronchitis, but may also be chronic changes (post inflammatory scar and bronchitis noted on prior CT scans)- Oxygen status: 3L- Decadron: Yes. Expected end date 8/29/22- Remdesivir: started 8/21, completed 5 days of treatment. LFT's stable. - DVT prophylaxis:Currently on full anticoagulation- Serial COVID labs ordered: Yes- Case Management/Social Services consulted: Yes; History of PE -Bilateral PE in July 2021 -Continue Eliquis 5 BID -wife reports Dr. recommended he stay on eliquis indefinitely; CAD -With cardiac arrest in 1998. PCI to LAD in Apr 1998. -Continue ASA, statin, BB. Ischemic cardiomyopathy -Prior EF 40-45% but most recent echo 6/30/22 with EF 55% -Continue BB. BPH -Continue bethanechol, finasteride, Flomax. Insomnia -Continue home Remeron and nightly Klonopin. Pulmonary nodules -Follows with Dr.  -Repeat CT chest in May 2022 stable if not improved so pulm recommended repeat CT chest in one year (May 2023).
Patient began to feel dizzy with headache almost immediately after receiving vaccine. Patient approached counter to let us know of symptoms and then fainted, hitting his head. Paramedics were called and arrived shortly after. Patient was given ice pack. Patient remained responsive throughout encounter.  Patient did not go to the hospital and instead went home with family after paramedics took vitals.
patient received a half dose of moderna in feb 2022 , when due to his immunocompromised status he should of received a full dose . patient also reported developing a rash on the bicep that lasted 2-3 days after vaccination then resolved.
Tingling in hands. Headache. Insomnia. Fatigue. Muscle aches. GI distress.
Patient is experiencing bruising, swelling and redness at injection site.  Redness is radiating down the upper arm to above the bend of the arm.  Patient is monitoring adverse reaction.
Information has been received from a nurse practitioner concerning a 14 year old female who, on an unspecified date, was vaccinated intramuscularly with her first dose of GARDASIL.  The patient discovered a cyst in one of her breasts sometime after receiving the vaccination.  The patient sought unspecified medical attention in the office.  No other information was provided.  Additional information has been requested.
Breakthrough covid case. Patient tested positive with an covid test at the Hospital. Presented to ER with c/o itchy throat, sore chest from forced cough and clearing throat, chest congestion. Prescribed Paxlovid. Discharged home.
On  the day of the shot, by Noon I could feel the vaccine moving into my throat and my  face. My throat and left cheek started to swell and turn slightly red.  I took more Benadryl and called my allergist in the afternoon. They told me I needed to get to the hospital for treatment.  At the hospital, they gave me steriods, benadryl and Pepcid in an IV.  After allowing this to work, they sent me home with a  steriod prescription for 60Mg for the next 5 days.  They asked me to follow up with my allergist if I had other issues , they also told me that I would not be able to get the 2nd dose of the vaccine.  Over the next several days, I continued to have issues with this redness that had grown over my entire face. I looked like I was totally sunburned.  I did not feel well, the redness was very hot, and I struggled with some breathing. I made an appointment on  Monday morning with my allergist, and they adjusted my allergy medicine and gave me more asteroids for 5 more days.   They advised me to use my nebulizer treatments as needed to remove the heaviness in my chest. This redness and swelling has moved around my body, almost as if I can see where the vaccine is at in my body.  It went from my head to my chest/back and right arm. Down to my abdomen, and then down below my knees.  In the morning, it is usually in my face and then it moves around during the day.  I can feel this fluid moving around in my body because the redness brings swelling/fluid.  This last saturday 3/6/2021 was horrible, it was in my right ear and right foot.  It was very painful and made me very dizzy. I struggled to walk.  Then on Sunday morning, I felt fine all day.  Today Monday, it feels like it is in my right foot again, but I feel like It is  getting better.
Initial report received on 21 August 2007 from a physician. A 50-year-old female patient, with a past medical history of "MVP" (mitral valve prolapse), "HTN" (hypertension) and chronic hepatitis C with normal "LFTS" (liver function tests); and who had concurrent illnesses of chronic thoracic neuropathy, and "quiet" rheumatoid arthritis, had received a left deltoid, intramuscular dose of Adacel, lot number C2734AA, on 12 June 2007. The patient had not received any other vaccinations within four weeks. Two days post-vaccination, the patient developed right upper brachial neuropathy with associated sensory loss. A neurology evaluation was completed, however the results of the evaluation were not reported. Treatment, diagnostic testing, and laboratory data were not provided. At the time of this report, the patient had not recovered.
Mild headache and heartburn five minutes after injection. No treatment. Vital signs stable. Heartburn completely resolved after about 15 minutes. Mild headache remained after 30 minutes.
Information regarding PREVNA was received from a healthcare professional regarding a patient who experienced swelling where site of injection was done. The patient received a dose on an unspecified date. The patient experienced where site of injection was done. Outcome of the event was unknown. No additional information was available at the time of this report.
Patient Return to Receive Pneumovax-23, but Receive Prevnar again in error. No adverse event. Just given Prevnar for 2nd time instead of Pneumovax-23. Only discovered when patient inquired if she had gotten the pneumonia shots.